Last update 08 May 2025

FLT3 x HASPIN

Basic Info

Related Targets
FLT3HASPIN

Related

1
Drugs associated with FLT3 x HASPIN
HSK-205
Target
FLT3 x HASPIN
Mechanism
FLT3 inhibitors [+1]
Active Org.
Purdue UniversityPurdue University
Originator Org.
Purdue UniversityPurdue University
Active Indication
Acute Myeloid Leukemia
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with FLT3 x HASPIN
Login to view more data
100 Translational Medicine associated with FLT3 x HASPIN
Login to view more data
0 Patents (Medical) associated with FLT3 x HASPIN
Login to view more data
1
Literatures (Medical) associated with FLT3 x HASPIN
RSC Medicinal Chemistry
Dual FLT3/haspin kinase inhibitor based on 3H-pyrazolo[4,3-f]quinoline scaffold with activities against acute myeloid leukemia

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free